lazabemide has been researched along with moclobemide in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Huang, G; Zhou, S | 1 |
| Dedecengiz, E; Erikci, A; Gokhan-Kelekci, N; Kaynak, FB; Salgin-Goksen, U; Tel, BC; Telli, G; Ucar, G; Yelekci, K | 1 |
| Cini, M; Da Prada, M; Dostert, P; Kettler, R; Marrari, P; Strolin Benedetti, M | 1 |
| Cesura, AM; Da Prada, M; Imhof, R; Lang, G; Muggli-Maniglio, D | 1 |
| Borroni, E; Colzi, A; d'Agostini, F; Da Prada, M; Kettler, R | 1 |
| Cesura, AM; Da Prada, M; Imhof, R; Keller, HH; Kettler, R; Kyburz, E; Muggli-Maniglio, D; Richards, JG; Saura Marti, J; Wyss, PC | 1 |
| Cesura, AM; Da Prada, M; Kettler, R; Richards, JG | 1 |
| Dingemanse, J; Hussain, Y; Korn, A | 1 |
| Kurasawa, M; Nakamura, K | 1 |
1 review(s) available for lazabemide and moclobemide
| Article | Year |
|---|---|
From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors.
Topics: Animals; Benzamides; Brain; Enzyme Inhibitors; Moclobemide; Monoamine Oxidase; Picolinic Acids; Rats; Thiazoles | 1990 |
1 trial(s) available for lazabemide and moclobemide
| Article | Year |
|---|---|
Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
Topics: Administration, Oral; Adrenergic Agents; Adult; Benzamides; Blood Pressure; Dose-Response Relationship, Drug; Drug Interactions; Humans; Injections, Intravenous; Male; Moclobemide; Monoamine Oxidase Inhibitors; Picolinic Acids; Tyramine | 1996 |
7 other study(ies) available for lazabemide and moclobemide
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase.
Topics: Animals; Brain; Carbon-13 Magnetic Resonance Spectroscopy; Dopamine; Drug Design; Female; Inhibitory Concentration 50; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Picolinic Acids; Proton Magnetic Resonance Spectroscopy; Rats; Serotonin; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2018 |
New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors.
Topics: Animals; Antidepressive Agents; Depression; Hep G2 Cells; Humans; Hydrazones; Mice; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Pyrazoles; Structure-Activity Relationship | 2021 |
The effects of lifelong treatment with MAO inhibitors on amino acid levels in rat brain.
Topics: Aging; Amino Acids; Animals; Benzamides; Brain Chemistry; Female; Moclobemide; Monoamine Oxidase Inhibitors; Picolinic Acids; Rats; Rats, Inbred Strains | 1990 |
Monoamine oxidase inhibition by moclobemide and 2-amino-ethyl carboxamide derivatives: mode of action and kinetic characteristics.
Topics: Animals; Benzamides; Blood Platelets; Brain; Cell Membrane; Female; Humans; In Vitro Techniques; Kinetics; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Picolinic Acids; Placenta; Pregnancy; Rats; Thiazoles | 1990 |
Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Corpus Striatum; Deamination; Dialysis; Dopamine; Homovanillic Acid; Male; Moclobemide; Monoamine Oxidase Inhibitors; Picolinic Acids; Rats; Rats, Inbred Strains; Thiazoles | 1990 |
Reversible, enzyme-activated monoamine oxidase inhibitors: new advances.
Topics: Animals; Benzamides; Brain; Clorgyline; Humans; In Vitro Techniques; Male; Moclobemide; Monoamine Oxidase Inhibitors; Phenelzine; Picolinic Acids; Piperidines; Rats; Selegiline | 1988 |
Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Bromocriptine; Diazepam; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Fear; Fluvoxamine; Haloperidol; Indophenol; Male; Maze Learning; Mecamylamine; Mice; Mice, Inbred ICR; Moclobemide; Motor Activity; Nicotine; Nicotinic Antagonists; Nortriptyline; Physostigmine; Picolinic Acids; Pyrrolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Social Behavior; Stress, Psychological | 2001 |